Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for CUE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
June 30, 2026 17.39M
March 31, 2026 16.38M
December 31, 2025 27.14M
September 30, 2025 18.67M
June 30, 2025 27.49M
March 31, 2025 13.14M
December 31, 2024 22.46M
September 30, 2024 32.42M
June 30, 2024 30.03M
March 31, 2024 41.03M
December 31, 2023 48.51M
September 30, 2023 54.69M
June 30, 2023 57.89M
March 31, 2023 66.20M
December 31, 2022 76.29M
September 30, 2022 59.18M
June 30, 2022 66.13M
March 31, 2022 67.93M
Date Value
December 31, 2021 64.37M
September 30, 2021 67.63M
June 30, 2021 73.92M
March 31, 2021 73.26M
December 31, 2020 84.87M
September 30, 2020 91.80M
June 30, 2020 84.93M
March 31, 2020 48.73M
December 31, 2019 59.41M
September 30, 2019 31.38M
June 30, 2019 28.31M
March 31, 2019 30.93M
December 31, 2018 39.26M
September 30, 2018 39.23M
June 30, 2018 45.79M
March 31, 2018 53.15M
December 31, 2017 63.58M
September 30, 2017 3.450M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Ironwood Pharmaceuticals, Inc. 79.13M
Fortress Biotech, Inc. 196.58M
Equillium, Inc. 57.16M
Legend Biotech Corp. 964.63M
Nurix Therapeutics, Inc. 443.53M